|
⚲
|
| Keyboard |
| Goodrich Katherine
✚
|
|
|---|---|
| CIK # | 0002044770 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0002044770] | |
| 4 | [0002044770] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Goodrich Katherine | |
| Tarsus Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Tarsus Pharmaceuticals Inc TARS
Common Stock
|
2025-12-15 | Option exercise | 2,233 | ||
|
Tarsus Pharmaceuticals Inc TARS
Restricted Stock Units · derivative
|
2025-12-15 | Option exercise | 2,233 | $0.00 | |
|
Tarsus Pharmaceuticals Inc TARS
Stock Option (right to buy) · derivative
|
2025-06-12 | Grant | 4,540 | $0.00 | |
|
Tarsus Pharmaceuticals Inc TARS
Restricted Stock Units · derivative
|
2025-06-12 | Grant | 2,954 | $0.00 | |
|
Tarsus Pharmaceuticals Inc TARS
Restricted Stock Units · derivative
|
2024-11-13 | Grant | 6,700 | $0.00 | |
|
Tarsus Pharmaceuticals Inc TARS
Stock Option (right to buy) · derivative
|
2024-11-13 | Grant | 10,000 | $0.00 |